http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190117800-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1c12a2a7eaad13b30d27ce6da591256 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N65-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-81 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N65-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00 |
| filingDate | 2009-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cc9c71f08d3ddf49f95c20e126f7f8f |
| publicationDate | 2019-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20190117800-A |
| titleOfInvention | Fruit extracts |
| abstract | The present invention provides a method for producing fruit extracts of eggplant, the fruit is treated to optimize the platelet aggregation inhibitory activity of the extract. The method comprises preparing a start mix of uniform fruit; Separating the soluble fraction from the fruit solids; Filtration of the aqueous fraction; And concentrating the active substances in the filtrate. The present invention provides fruit extracts and glycosylated phenolic acid or phenolic esters or derivatives thereof prepared by this method; Provided are fruit extracts comprising glycosylated flavonoids and nucleosides. The extract of the present invention is useful as a medicament for the treatment or prevention of diseases characterized by inadequate platelet aggregation. In particular, the medical treatment or prevention of diseases characterized by inadequate platelet aggregation reduces the platelet aggregation to maintain heart health; To benefit the circulation; It may be useful to normalize or benefit blood flow. |
| priorityDate | 2008-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 179.